Page last updated: 2024-09-04

febuxostat and Anemia, Sickle Cell

febuxostat has been researched along with Anemia, Sickle Cell in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	1 (100.00)	2.80

Authors

Authors	Studies
Bachman, TN; Baust, JJ; Du, J; Ghosh, S; Hahn, SA; Kelley, EE; Lebensburger, JD; Lewis, SE; McMahon, B; Ofori-Acquah, SF; Oh, JY; Patel, RP; Schmidt, HM; Straub, AC; Vitturi, DA; Wang, Y; Williams, XM; Wood, KC; Yuan, S	1

Other Studies

1 other study(ies) available for febuxostat and Anemia, Sickle Cell

Article	Year
Xanthine Oxidase Drives Hemolysis and Vascular Malfunction in Sickle Cell Disease. Arteriosclerosis, thrombosis, and vascular biology, 2021, Volume: 41, Issue:2 Topics: Anemia, Sickle Cell; Animals; Disease Models, Animal; Enzyme Inhibitors; Erythrocytes; Febuxostat; Hemodynamics; Hemolysis; Liver; Male; Mice, Inbred C57BL; Mice, Knockout; Pulmonary Artery; Ventricular Function; Xanthine Oxidase	2021

Article

Year

Xanthine Oxidase Drives Hemolysis and Vascular Malfunction in Sickle Cell Disease.

Arteriosclerosis, thrombosis, and vascular biology, 2021, Volume: 41, Issue:2

Topics: Anemia, Sickle Cell; Animals; Disease Models, Animal; Enzyme Inhibitors; Erythrocytes; Febuxostat; Hemodynamics; Hemolysis; Liver; Male; Mice, Inbred C57BL; Mice, Knockout; Pulmonary Artery; Ventricular Function; Xanthine Oxidase

2021